Obtaining Undifferentiated Cells From Testis Biopsy
Isolation, Culture and Characterization Stem Cells From Testis Biopsy
1 other identifier
interventional
65
1 country
1
Brief Summary
The purpose of this study is to isolate and culture stem cell from adult human testicular biopsies for future transplantation in fertility preservation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2009
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2009
CompletedFirst Submitted
Initial submission to the registry
June 7, 2011
CompletedFirst Posted
Study publicly available on registry
June 17, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2011
CompletedOctober 19, 2015
March 1, 2014
2.2 years
June 7, 2011
October 16, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Assessment of potential germinal and pluripotent of the isolated cultures.
•The spermatogonial cells isolated from testicular biopsies of azoospermic patients will be matured in vitro for thegeneration of sperm for infertility treatment. \* Undifferentiated cells of the testis biopsy will be characterized as degrees of plasticity for proof that they are capable of regeneration spermatogenesis.
one month
Study Arms (1)
tissue from biopsies
NO INTERVENTIONInterventions
1. Obtention of excess tissue from testicular biopsies and maintained in 4ºC until procedures. 2. Digestion of the biopsies through controlled enzymes 3. Replication of the cells 4. Selection undifferentiated cells 5. Expansion of the purification cells population 6. Characterization of the cell population 7. Assessment of pluripotent and germinal cell potential. 8. Possible maturation of the cells.
Eligibility Criteria
You may qualify if:
- azoospermic patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Igenomixlead
Study Sites (1)
IVI Valencia
Valencia, 46015, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Carlos Simon, MDPhD
IVI Valencia
- PRINCIPAL INVESTIGATOR
Marcia Riboldi, PhD
Fundación IVI
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator; Gynecologist IVI Valencia
Study Record Dates
First Submitted
June 7, 2011
First Posted
June 17, 2011
Study Start
May 1, 2009
Primary Completion
July 1, 2011
Study Completion
July 1, 2011
Last Updated
October 19, 2015
Record last verified: 2014-03